share_log
Reuters ·  05/23 17:08

IDEAYA Biosciences Inc: Darovasertib Was Generally Well Tolerated With No Drug-Related Serious Adverse Events

IDEAYA Biosciences Inc:Darovasertib的耐受性总体良好,没有与药物相关的严重不良事件

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发